A second major study from the Cocoa Supplement and Multivitamin Outcomes Study has concluded that a daily intake of multivitamin supplements can help improve memory as well as slow cognitive aging in older adults.
Multivitamin supplementation holds promise as a safe, accessible and affordable approach to protecting cognitive health in older adults.
(Source: Pixabay)
Boston/USA – Few effective strategies have been shown in randomized clinical trials to improve memory or slow cognitive decline among older adults. Nutritional interventions may play an important role because the brain requires several nutrients for optimal health, and deficiencies in one or more of these nutrients may accelerate cognitive decline. The Cocoa Supplement and Multivitamin Outcomes Study (Cosmos), a large-scale nation-wide randomized trial directed by researchers at Brigham and Women’s Hospital (BWH), a founding member of Mass General Brigham, included two separate clinical trials (Cosmos-Web and Cosmos-Mind) testing multivitamin supplementation on changes in cognitive function. In a study published recently in The American Journal of Clinical Nutrition, researchers from the Brigham and their collaborators at Columbia University report from Cosmos-Web that daily multivitamin supplements, compared to placebo, improved memory among participants. The study is the second from Cosmos, along with the previously published Cosmos-Mind, to find an improvement in memory function among those taking a multivitamin.
“The findings that a daily multivitamin improved memory and slowed cognitive decline in two separate studies in the Cosmos randomized trial is remarkable, suggesting that multivitamin supplementation holds promise as a safe, accessible and affordable approach to protecting cognitive health in older adults,” said co-author JoAnn Manson, MD, chief of the Brigham’s Division of Preventive Medicine. Manson is a co-leader of the parent Cosmos trial with Howard Sesso, ScD, associate director of the Brigham’s Division of Preventive Medicine.
Sesso adds, “With these two studies on cognition in hand for Cosmos, and more to come in Cosmos, it is critical to understand how a daily multivitamin may protect against memory loss and cognitive decline, and whether particular subgroups based on nutritional status or other factors may benefit more, or less.”
The newly published Cosmos-Web trial included more than 3,500 participants aged 60 and older who completed novel web-based assessments of memory and cognition annually over 3 years. Compared to the placebo group, participants randomized to multivitamin supplementation did significantly better on the memory tests at the prespecified primary time point of 1 year, with benefits sustained across the 3 years of follow-up. The researchers estimated that the multivitamin intervention improved memory performance by the equivalent of 3.1 years compared to the placebo group. Intriguingly, both Cosmos cognitive studies also showed that the participants who benefitted the most may be those with a history of cardiovascular disease.
“Because of our innovative approach of assessing cognitive outcomes using internet-based tests, we were able to examine the effects of a multivitamin in thousands of study participants. The findings are promising and certainly set the stage for important follow-up studies about the impact of multivitamin supplementation on cognition,” said Adam Brickman, PhD, who co-led the Cosmos-Web study with Lok-Kin Yeung, PhD, at Columbia University. “Most older adults are worried about memory changes that occur with aging. Our study suggests that supplementation with multivitamins may be a simple and inexpensive way for older adults to slow down memory loss,” added Yeung.
Results from Cosmos-Web, conducted as a collaboration between the Brigham and Columbia University, provide confirmation of earlier findings from Cosmos-Mind linking daily multivitamins to slowing of cognitive decline. Cosmos-Mind, which was conducted as a collaboration between the Brigham and Wake Forest School of Medicine, had tested 2,200 older adults for 3 years and showed that randomized assignment to a daily multivitamin supplement was associated with a 60 % slowing of global cognitive aging compared to placebo, equivalent to 1.8 years reduction in cognitive decline (study was funded by the National Institute on Aging and published in Alzheimer’s and Dementia in September 2022).
The authors note that the Cosmos-Web study provides evidence that multivitamin supplementation has cognitive benefits but further research will be necessary to identify the specific nutrients contributing the most to this benefit and the underlying mechanisms involved. Additional research is also needed to determine whether the findings are generalizable to a more diverse study population with lower educational levels and lower socioeconomic status.
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.